Literature DB >> 25561197

Changing operative strategy from abdominoperineal resection to sphincter preservation in T3 low rectal cancer after downstaging by neoadjuvant chemoradiation: a preliminary report.

Khaled M Madbouly1, Ahmed M Hussein.   

Abstract

OBJECTIVE: The objective of this study is to assess oncological outcome after changing operative strategy from abdominoperineal resection (APR) to sphincter preservation (SP) in T3 low rectal carcinomas downstaged by neoadjuvant chemoradiation (nCRT). PATIENTS AND METHODS: This was a prospective observational study performed at academic medical centers. Patients with T3 rectal carcinoma, (<1 cm from the top of anal sphincter) received long-course neoadjuvant chemoradiation. Decision before chemoradiation was APR in all patients. Patients who had successful downstaging were included in the study. Low anterior resection (LAR) was performed after 8-11 weeks from completion of nCRT. Follow-up duration ranged from 4 to 6 years. Salvage surgery was done for local recurrence when possible. The primary endpoint of the study was disease-free survival. Secondary endpoints were morbidity, mortality, continence, and oncologic results of salvage surgery after recurrence.
RESULTS: LAR with colorectal or coloanal anastomosis were done in 9 and 36 patients, respectively. After a mean follow-up of 57 months (range 48-70), local recurrences was reported in 4 patients (8.8 %), one of them had also distant metastasis while 2 patients (4.4 %) had only distant metastasis. Disease-free and overall survival rates were 87 and 89 %, respectively. Three of 4 patients with local recurrence (the fourth had liver metastasis) underwent salvage APR with free safety margins. Follow-up after salvage surgery for 31, 33, and 37 months revealed no recurrences. Wexner continence score ≤4 was noted in 39 patients; while major incontinence (Wexner score >12) was noted in 2 patients.
CONCLUSIONS: For selected patients of T3 low rectal cancer, changing operative strategy from APR to SP after downstaging by nCRT can be done in motivated patients with good sphincter function. Disease-free survival rates and continence are comparable to patients had APR and to previous publications with decision made before nCRT. With strict follow-up, early diagnosis of recurrence and salvage surgery with free resection margins can be achieved.

Entities:  

Mesh:

Year:  2015        PMID: 25561197     DOI: 10.1007/s00268-014-2930-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  38 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis.

Authors:  Luigi Zorcolo; Alan S Rosman; Angelo Restivo; Michele Pisano; Giuseppe R Nigri; Alessandro Fancellu; Marcovalerio Melis
Journal:  Ann Surg Oncol       Date:  2012-03-21       Impact factor: 5.344

Review 3.  Laparoscopic versus open total mesorectal excision for rectal cancer.

Authors:  S Breukink; J Pierie; T Wiggers
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 4.  Etiology and management of fecal incontinence.

Authors:  J M Jorge; S D Wexner
Journal:  Dis Colon Rectum       Date:  1993-01       Impact factor: 4.585

5.  Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience.

Authors:  N A Janjan; V S Khoo; J Abbruzzese; R Pazdur; R Dubrow; K R Cleary; P K Allen; P M Lynch; G Glober; R Wolff; T A Rich; J Skibber
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-15       Impact factor: 7.038

6.  Pushing the envelope beyond a centimeter in rectal cancer: oncologic implications of close, but negative margins.

Authors:  Timothy L Fitzgerald; Jason Brinkley; Emmanuel E Zervos
Journal:  J Am Coll Surg       Date:  2011-08-19       Impact factor: 6.113

7.  Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival.

Authors:  Angelita Habr-Gama; Rodrigo Oliva Perez; Wladimir Nadalin; Sérgio Carlos Nahas; Ulysses Ribeiro; Afonso Henrique Silva E Sousa; Fábio Guilherme Campos; Desidério Roberto Kiss; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

8.  Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation?

Authors:  Vijai Simha; Rakesh Kapoor; Rajesh Gupta; Amit Bahl; Ritambhara Nada
Journal:  J Gastrointest Oncol       Date:  2014-08

9.  The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.

Authors:  Koen C M J Peeters; Corrie A M Marijnen; Iris D Nagtegaal; Elma Klein Kranenbarg; Hein Putter; Theo Wiggers; Harm Rutten; Lars Pahlman; Bengt Glimelius; Jan Willem Leer; Cornelis J H van de Velde
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

10.  Total mesorectal excision (TME) with laparoscopic approach: 226 consecutive cases.

Authors:  Carlo Staudacher; Saverio Di Palo; Andrea Tamburini; Andrea Vignali; Elena Orsenigo
Journal:  Surg Oncol       Date:  2007-11-28       Impact factor: 3.279

View more
  4 in total

1.  Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study.

Authors:  Yu-Tso Liao; Yu-Lin Lin; John Huang; Ji-Shiang Hung; Been-Ren Lin
Journal:  Int J Colorectal Dis       Date:  2020-10-30       Impact factor: 2.571

2.  Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review.

Authors:  Ferdinando D'Amico; Steven D Wexner; Carolynne J Vaizey; Célia Gouynou; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-07-17       Impact factor: 4.623

3.  Robotic-assisted total mesorectal excision with the single-docking technique for patients with rectal cancer.

Authors:  Ching-Wen Huang; Hsiang-Lin Tsai; Yung-Sung Yeh; Wei-Chih Su; Ming-Yii Huang; Chun-Ming Huang; Yu-Tang Chang; Jaw-Yuan Wang
Journal:  BMC Surg       Date:  2017-12-05       Impact factor: 2.102

4.  Survival after Abdominoperineal and Sphincter-Preserving Resection in Nonmetastatic Rectal Cancer: A Population-Based Time-Trend and Propensity Score-Matched SEER Analysis.

Authors:  Rene Warschkow; Sabrina M Ebinger; Walter Brunner; Bruno M Schmied; Lukas Marti
Journal:  Gastroenterol Res Pract       Date:  2017-01-18       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.